Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression

On June 15th, 2004, FDA’s Medical Devices Panel recommended that the U.S. Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression - Updates

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.